GK Wealth Management
ELDN icon

GK Wealth Management’s Eledon Pharmaceuticals ELDN Stock Holding History

GK Wealth Management’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$20.2K Sell
7,987
-3,500
-30% -$11.8K 0.01% 652
2026
Q2 		$45.3K Buy
+11,487
New +$41.8K 0.02% 233

Other funds holding ELDN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Triumph Capital Management
Triumph Capital Management Denver, Colorado $573M AUM 15.32% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Daytona Street Capital
Daytona Street Capital Saint Louis, Missouri $141M AUM 14.38% 1-Year Est. Return
Prodigy Asset Management
Prodigy Asset Management Omaha, Nebraska $335M AUM 5.94% 1-Year Est. Return
Farmers & Merchants Investments Inc
Farmers & Merchants Investments Inc Lincoln, Nebraska $4.16B AUM 24.97% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

GK Wealth Management's ELDN Position: Q3 2026 in Review

GK Wealth Management reduced its Eledon Pharmaceuticals (ELDN) stake by 30% in Q3 2026, selling an estimated $11.8K and leaving 7,987 shares worth $20.2K. The position accounts for 0.01% of the portfolio, ranked #652.

GK Wealth Management first reported a position in ELDN in Q2 2026 and has held it in 2 quarters since. The position peaked at $45.3K in Q2 2026. 65 funds tracked by Wall St. Rank hold ELDN as of Q3 2026.

  • GK Wealth Management held 7,987 shares of Eledon Pharmaceuticals worth $20.2K as of Q3 2026.
  • GK Wealth Management sold 3,500 Eledon Pharmaceuticals shares in Q3 2026, an estimated $11.8K.
  • Eledon Pharmaceuticals made up 0.01% of GK Wealth Management's portfolio in Q3 2026, its #652 holding.
  • GK Wealth Management first reported a position in Eledon Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • GK Wealth Management's Eledon Pharmaceuticals position peaked at $45.3K in Q2 2026.
  • 65 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q3 2026.

Based on GK Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.